Find a Clinical Trial
Filter
Dompe' Reparixin study
COVID-19
All genders
18+
Recruiting now
Department of Medicine, Division of Geographic Medicine + Infectious Diseases
Collagen Urine Assay
Male
50-80
Recruiting now
Department of Urology
AN2 EBO301 MAC Study
Mycobacterial disease
All genders
18+
Recruiting now
Department of Medicine, Division of Geographic Medicine + Infectious Diseases
Moderna mRNA 1273 study
COVID-19
All genders
0-12
Recruiting now
Department of Medicine, Division of Geographic Medicine + Infectious Diseases
HGB-210
Sickle cell anemia
All genders
2-50
Recruiting now
Department of Medicine, Department of Pediatrics, Division of Hematology/Oncology, Cancer Center
Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin (VOLGA)
Bladder cancer
All genders
18+
Recruiting now
Department of Medicine, Cancer Center
Letermovir for secondary prophylaxis for CMV disease in solid organ transplant recipients
Cytomegalovirus infection
All genders
18-75
Recruiting now
Department of Medicine, Division of Geographic Medicine + Infectious Diseases
LYS228 Pharmacokinetics for Complicated UTI
Urinary tract infections
All genders
18-85
Recruiting now
Department of Urology
ANHL1931
Lymphoma
All genders
2+
Recruiting now
Department of Medicine, Department of Pediatrics, Division of Hematology/Oncology, Cancer Center
A Long COVID-19 Observational Pilot Study Using Wearable Devices
Detection and Risk Assessment in Post COVID-19 Infection – A Long COVID-19 Observational Pilot Study
COVID-19
All genders
18+
Recruiting now
Department of Medicine, Division of Geographic Medicine + Infectious Diseases